Positions

Overview

  • Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. For this effort and her other research efforts, she received the 2014 Young Investigator Award from the American Sexually Transmitted Diseases Association. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis.  Current Opinion in Infectious Diseases.  33:59-65. 2020
    2020 Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.  Current Opinion in Infectious Diseases.  33:73-77. 2020
    2020 Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic Meeting.  Sexually Transmitted Diseases.  47:5-11. 2020
    2020 Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic.  International Journal of STD and AIDS.  2020
    2019 Trichomonas vaginalis Virus among Women with Trichomoniasis and Associations with Demographics, Clinical Outcomes, and Metronidazole Resistance.  Clinical Infectious Diseases.  69:2170-2176. 2019
    2019 Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women.  Sexually Transmitted Infections.  95:511-515. 2019
    2019 Pharmacokinetic and Pharmacodynamic Effects of Metronidazole May Account for the Superior Efficacy of Multidose Therapy among Women with Trichomoniasis.  Sexually Transmitted Diseases.  46:751-752. 2019
    2019 An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis.  Journal of Infectious Diseases.  220:1399-1405. 2019
    2019 Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?.  Sexually Transmitted Diseases.  46:E57-E59. 2019
    2019 Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.  Sexually Transmitted Diseases.  46:312-316. 2019
    2019 Trichomonas vaginalis virus: a review of the literature.  International Journal of STD and AIDS.  30:496-504. 2019
    2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients.  International Journal of STD and AIDS.  30:344-352. 2019
    2019 In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene Sequencing.  Journal of Infectious Diseases.  219:305-314. 2019
    2019 Quantitative evaluation on the challenges and opportunities in the recruitment of young Black men who have sex with men for sexual health research in the southern US.  Sexual Health.  2019
    2019 Recent advances in the epidemiology, diagnosis, and management of trichomonas vaginalis infection [version 1; peer review: 2 approved].  F1000Research.  8. 2019
    2019 Treatment recommendations for trichomoniasis in women.  Lancet Infectious Diseases.  19:20-21. 2019
    2018 Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?.  PLoS ONE.  13. 2018
    2018 Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.  Lancet Infectious Diseases.  18:1251-1259. 2018
    2018 Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study.  Journal of Infectious Diseases.  218:966-978. 2018
    2018 Why does trichomonas vaginalis continue to be a "neglected" sexually transmitted infection?.  Clinical Infectious Diseases.  67:218-220. 2018
    2018 Psychosocial stressors and sexual health among Southern African American women who have sex with women.  LGBT Health.  5:234-241. 2018
    2018 Is There a Continuum of Risk for Sexually Transmitted Infections among African American Women?.  Sexually Transmitted Diseases.  45:e20-e22. 2018
    2018 Reverse syphilis screening algorithm fails to demonstrate cost effectiveness in persons living with HIV.  International Journal of STD and AIDS.  29:563-567. 2018
    2018 Comparisons of vaginal flora patterns among sexual behaviour groups of women: Implications for the pathogenesis of bacterial vaginosis.  Sexual Health.  15:61-67. 2018
    2017 Budgetary impact of compliance with sti screening guidelines in persons living with HIV.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology.  74:303-308. 2017
    2017 Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers.  Southern Medical Journal.  110:161-167. 2017
    2017 Sexual orientation and sexual health services utilization among women in the United States.  Preventive Medicine.  95:74-81. 2017
    2017 Trichomonas vaginalis treated with boric acid in a metronidazole allergic female.  Sexually Transmitted Diseases.  44:120. 2017
    2016 Sexual Orientation and Sexual and Reproductive Health among African American Sexual Minority Women in the U.S. South.  Women's Health Issues.  26:612-621. 2016
    2016 Chlamydia trachomatis infection in African American women who exclusively have sex with women.  International Journal of STD and AIDS.  27:978-983. 2016
    2016 Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.  Annals of Pharmacotherapy.  50:747-757. 2016
    2016 Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.  Journal of Infectious Diseases.  214:S1-S5. 2016
    2016 Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.  Sexually Transmitted Diseases.  43:483-488. 2016
    2015 Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.  Clinical Infectious Diseases.  61:601-606. 2015
    2015 Accuracy of self-report of sexual activity among adolescent girls: Implications for interpretation of vaginal flora patterns.  mBio.  6:1-2. 2015
    2015 Editorial commentary: Women who have sex with women: A unique population for studying the pathogenesis of bacterial vaginosis.  Clinical Infectious Diseases.  60:1054-1056. 2015
    2014 Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.  Clinical Infectious Diseases.  59:834-841. 2014
    2014 Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: A conceptual model.  Journal of Infectious Diseases.  210:338-343. 2014
    2014 Antibiotic hypersensitivity reactions and approaches to desensitization.  Clinical Infectious Diseases.  58:1140-1148. 2014
    2014 Association between BVAB1 and high Nugent scores among women with bacterial vaginosis.  Diagnostic Microbiology and Infectious Disease.  80:321-323. 2014
    2014 Families of choice and noncollegiate sororities and fraternities among lesbian and bisexual african-American women in a southern community: Implications for sexual and reproductive health research.  Sexual Health.  11:24-30. 2014
    2014 Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: A mixed methods study.  Sexually Transmitted Infections.  90:165-170. 2014
    2014 Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men.  Sexual Health.  11:592-593. 2014
    2014 Lymphogranuloma venereum proctitis and clostridium difficile colitis in an HIV-infected patient.  Infectious Diseases in Clinical Practice.  22. 2014
    2014 Reply to hickey and forney.  Journal of Infectious Diseases.  210:1683-1684. 2014
    2014 Rickettsia parkeri: Eschar diagnosis.  Journal of The American Academy of Dermatology.  71. 2014
    2014 Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk.  Sexually Transmitted Diseases.  41:611-617. 2014
    2014 Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure.  Sexually Transmitted Diseases.  41:58-60. 2014
    2013 Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis.  PLoS ONE.  8. 2013
    2013 Diagnostic rates differ on the basis of the number of read days with the use of the Inpouch culture system for Trichomonas Vaginalis screening.  Journal of Clinical Microbiology.  51:3875-3876. 2013
    2013 Bacterial vaginosis among African American women who have sex with women.  Sexually Transmitted Diseases.  40:751-755. 2013
    2013 The clinical spectrum of Trichomonas vaginalis infection and challenges to management.  Sexually Transmitted Infections.  89:423-425. 2013
    2013 Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic.  Sexually Transmitted Infections.  89:514-518. 2013
    2013 Sexual behaviors, perception of sexually transmitted infection risk, and practice of safe sex among southern african american women who have sex with women.  Sexually Transmitted Diseases.  40:395-400. 2013
    2013 Misperceptions regarding protective barrier method use for safer sex among African-American women who have sex with women.  Sexual Health.  10:138-141. 2013
    2013 Gardnerella vaginalis: Still a prime suspect in the pathogenesis of bacterial vaginosis.  Current Infectious Disease Reports.  15:130-135. 2013
    2012 Genetic characterization of Trichomonas vaginalis isolates by use of multilocus sequence typing.  Journal of Clinical Microbiology.  50:3293-3300. 2012
    2012 Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: Successful treatment with boric acid.  Sexual Health.  9:389-391. 2012
    2012 A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndrome.  American Journal of the Medical Sciences.  343:421-425. 2012
    2012 Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships..  Sexually Transmitted Diseases.  39:556-558. 2012
    2012 Hansen's disease (Leprosy): Current and future pharmacotherapy and treatment of disease-related immunologic reactions.  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  32:27-37. 2012
    2011 Sexually transmitted infections and risk behaviors among African American women who have sex with women: Does sex with men make a difference?.  Sexually Transmitted Diseases.  38:1118-1125. 2011
    2011 Slowly progressive annular skin lesions in an elderly patient..  Clinical Infectious Diseases.  52. 2011
    2010 Enterococcus faecium vertebral osteomyelitis and its association with infective endocarditis.  Infectious Diseases in Clinical Practice.  18:80-82. 2010
    2009 Vulvar vaccinia infection after sexual contact with a smallpox vaccinee.  American Journal of the Medical Sciences.  337:289-291. 2009
    2008 Pneumococcal septic arthritis as the initial presentation of multiple myeloma.  Clinical and Laboratory Haematology.  30:82-83. 2008
    2008 Vomiting and diarrhea in a 51-year-old woman with splenectomy.  Chest.  134:438-441. 2008
    2005 Mystery in the basement..  Journal of the Mississippi State Medical Association.  46:198-201. 2005

    Chapter

    Year Title Altmetric
    2013 Vaginal Infections.  473-483. 2013

    Research Overview

  • HIV and sexually transmitted infections (specifically vaginal infections - BV and trichomoniasis) among difficult-to-reach populations of women, including African American women who have sex with women.

    • Principal Investigator On

    Investigator On

  • Private Grant  awarded by SPEEDX PTY. LTD. 2019 - 2023
  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2020
  • Private Grant  awarded by NEUMODX MOLECULAR 2019 - 2020
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2018 - 2020
  • The UAB STI CRC - Project 2: Strain Diversity among Gardnerella: Association with Progression to BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • Private Grant  awarded by SPEEDX PTY. LTD. 2018 - 2020
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2019 - 2020
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco 2018 - 2020
  • Private Grant  awarded by CEPHEID 2018 - 2019
  • Private Grant  awarded by RHEONIX, INC. 2014 - 2019
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2018 - 2019
  • Private Grant  awarded by ATLAS GENETICS 2017 - 2019
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by LUMINEX CORPORATION 2018 - 2019
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2017 - 2018
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2017 - 2018
  • Private Grant  awarded by ABBOTT MOLECULAR 2018
  • Private Grant  awarded by CLICK DIAGNOSTICS 2016 - 2018
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2016 - 2018
  • Private Grant  awarded by CURATEK PHARMACEUTICALS 2015 - 2018
  • Private Grant  awarded by HOLOGIC, INC. 2017 - 2018
  • Private Grant  awarded by LUMINEX CORPORATION 2017
  • Private Grant  awarded by BECKMAN COULTER, INC. 2015 - 2017
  • Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2017
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2016 - 2017
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2016 - 2017
  • Private Grant  awarded by STARPHARMA 2014 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2016 - 2017
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2017
  • Private Grant  awarded by BD DIAGNOSTICS 2015 - 2017
  • Private Grant  awarded by FLORA BIOSCIENCE 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2014 - 2016
  • Private Grant  awarded by VIAMET PHARMACEUTICALS, INC. - NEW 2014 - 2016
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2015 - 2016
  • Private Grant  awarded by ELITECH GROUP MOLECULAR 2014 - 2016
  • Private Grant  awarded by QUIDEL CORPORATION 2015 - 2016
  • Private Grant  awarded by CEPHEID 2014 - 2016
  • Private Grant  awarded by ALFA-WASSERMAN, INC. 2015 - 2016
  • Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings  awarded by University of California, San Francisco 2014 - 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by BIOHELIX CORPORATION 2013 - 2015
  • JCDH Contract NO: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2014 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2012 - 2015
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2013 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2014 - 2015
  • Private Grant  awarded by WATSON LABORATORIES, INC. 2014 - 2015
  • Private Grant  awarded by ACTIVBIOTICS, INC. 2012 - 2014
  • Private Grant  awarded by HOLOGIC, INC. 2014
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2014
  • Private Grant  awarded by CEPHEID 2013 - 2014
  • Jefferson County Department of Health Contract No. DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2012 - 2014
  • STD/HIV Prevention Training Center  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION 2011 - 2014
  • Private Grant  awarded by GEN-PROBE, INC. 2013 - 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2014
  • Private Grant  awarded by CEPHEID 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2012 - 2014
  • Private Grant  awarded by COPAN DIAGNOSTICS, INC 2012 - 2013
  • Private Grant  awarded by SANOFI PASTEUR LIMITED 2009 - 2013
  • Private Grant  awarded by GEN-PROBE, INC. 2012 - 2013
  • Private Grant  awarded by MEDICIS PHARMACEUTICAL CORPORATION 2012 - 2013
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2013
  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-formulated Pessaries vs Placebo for Preventing Vaginal Infections in HIV-Seronegative Women DMID #09-0070  awarded by University of California, San Francisco 2010 - 2013
  • JCDH Contract No DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2011 - 2012

    • Education And Training

  • Master of Science in Health Professions and Related Clinical Sciences, University of Alabama at Birmingham 2017
  • Doctor of Medicine, Texas A&M University System Health Science Center 2003
  • Bachelor of Arts in Biology, University of Texas System : Austin 1998
  • University of Mississippi Medical Center, Internship 2004
  • University of Mississippi Medical Center, Residency 2006
  • University of Mississippi Medical Center, Postdoctoral Fellowship 2009

    • Full Name

  • Christina Muzny

    • Blazerid

  • cmuzny